Xin An

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Cancer medicine

Korean journal of radiology

BJU international

Cancer

Sun Yat-sen University Cancer Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Sun Yat-sen University Cancer Center Aug 01 2007

China

PHD :: medical oncology

Publications

Ying Chen, Wen-Xia Li, Jia-Hua Wu, Geng-Hang Chen, Chun-Min Yang, Hai Lu, Xi Wang, Shu-Sen Wang, Heng Huang, Li Cai, Li Zhao, Rou-Jun Peng, Ying Lin, Jun Tang, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, An-Qin Zhang, Fei Xu, Xi-Wen Bi, Jia-Jia Huang, Weiwei Xiao, Dan-Mei Pang, Cong Xue, Yan-Xia Shi, Zhen Yu He, Huan-Xin Lin, Xin An, Wen Xia, Ye Cao, Ying Guo, Ruo-Xi Hong, Kui-Kui Jiang, Yong-Yi Zhong, Ge Zhang, Piyawan Tienchaiananda, Masahiro Oikawa, Zhong-Yu Yuan, Qian-Jun Chen
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial. Breast cancer (Dove Medical Press) 16 (2024)
Mei-Ting Chen, Lu Li, Qing Xia, Xiaobing Chen, Zijun Liao, Chang Wang, Bo Shen, Min Zhou, Qingyuan Zhang, Yanqiao Zhang, Liting Qian, Xianglin Yuan, Zhehai Wang, Cong Xue, Xin An, Bin Liu, Kangsheng Gu, Mei Hou, Xiaojia Wang, Wei Wang, Enxiao Li, Jincai Zhong, Jing Cheng, Yongqian Shu, Nong Yang, Huaqing Wang, Runxiang Yang, Tianshu Liu, Ting Deng, Fei Ma, Wangjun Liao, Wensheng Qiu, Yu Chen, Xi Chen, Mingzhi Zhang, Ruilian Xu, Xiaoling Li, Jifeng Feng, Yi Ba, Yanxia Shi
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study. Cancer 130 (S8) (2024)
Ying Chen, Wen-Xia Li, Jia-Hua Wu, Geng-Hang Chen, Chun-Min Yang, Hai Lu, Xi Wang, Shu-Sen Wang, Heng Huang, Li Cai, Li Zhao, Rou-Jun Peng, Ying Lin, Jun Tang, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, An-Qin Zhang, Fei Xu, Xi-Wen Bi, Jia-Jia Huang, Weiwei Xiao, Dan-Mei Pang, Cong Xue, Yan-Xia Shi, Zhen Yu He, Huan-Xin Lin, Xin An, Wen Xia, Ye Cao, Ying Guo, Ruo-Xi Hong, Kui-Kui Jiang, Yong-Yi Zhong, Ge Zhang, Piyawan Tienchaiananda, Masahiro Oikawa, Zhong-Yu Yuan, Qian-Jun Chen
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial. Breast cancer (Dove Medical Press) 16 (2024)
Mei-Ting Chen, Lu Li, Qing Xia, Xiaobing Chen, Zijun Liao, Chang Wang, Bo Shen, Min Zhou, Qingyuan Zhang, Yanqiao Zhang, Liting Qian, Xianglin Yuan, Zhehai Wang, Cong Xue, Xin An, Bin Liu, Kangsheng Gu, Mei Hou, Xiaojia Wang, Wei Wang, Enxiao Li, Jincai Zhong, Jing Cheng, Yongqian Shu, Nong Yang, Huaqing Wang, Runxiang Yang, Tianshu Liu, Ting Deng, Fei Ma, Wangjun Liao, Wensheng Qiu, Yu Chen, Xi Chen, Mingzhi Zhang, Ruilian Xu, Xiaoling Li, Jifeng Feng, Yi Ba, Yanxia Shi
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study. Cancer 130 (S8) (2024)
Mei-Ting Chen, Lu Li, Qing Xia, Xiaobing Chen, Zijun Liao, Chang Wang, Bo Shen, Min Zhou, Qingyuan Zhang, Yanqiao Zhang, Liting Qian, Xianglin Yuan, Zhehai Wang, Cong Xue, Xin An, Bin Liu, Kangsheng Gu, Mei Hou, Xiaojia Wang, Wei Wang, Enxiao Li, Jincai Zhong, Jing Cheng, Yongqian Shu, Nong Yang, Huaqing Wang, Runxiang Yang, Tianshu Liu, Ting Deng, Fei Ma, Wangjun Liao, Wensheng Qiu, Yu Chen, Xi Chen, Mingzhi Zhang, Ruilian Xu, Xiaoling Li, Jifeng Feng, Yi Ba, Yanxia Shi
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study. Cancer 130 (S8) (2024)
Mei-Ting Chen, Lu Li, Qing Xia, Xiaobing Chen, Zijun Liao, Chang Wang, Bo Shen, Min Zhou, Qingyuan Zhang, Yanqiao Zhang, Liting Qian, Xianglin Yuan, Zhehai Wang, Cong Xue, Xin An, Bin Liu, Kangsheng Gu, Mei Hou, Xiaojia Wang, Wei Wang, Enxiao Li, Jincai Zhong, Jing Cheng, Yongqian Shu, Nong Yang, Huaqing Wang, Runxiang Yang, Tianshu Liu, Ting Deng, Fei Ma, Wangjun Liao, Wensheng Qiu, Yu Chen, Xi Chen, Mingzhi Zhang, Ruilian Xu, Xiaoling Li, Jifeng Feng, Yi Ba, Yanxia Shi
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study. Cancer (2024)
Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Mei-Ting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shu-Sen Wang, Yanxia Shi, Xin An
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Cancer medicine (2023)
Lichao Wei, Zaishang Li, Sheng-Jie Guo, Huali Ma, Yanxia Shi, Xin An, Kangbo Huang, Longbin Xiong, Ting Xue, Zhiling Zhang, Kai Yao, Junhang Luo, Hui Han
Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy. Cancer (2023)
Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Mei-Ting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shu-Sen Wang, Yanxia Shi, Xin An
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Cancer medicine (2023)
Lichao Wei, Zaishang Li, Sheng-Jie Guo, Huali Ma, Yanxia Shi, Xin An, Kangbo Huang, Longbin Xiong, Ting Xue, Zhiling Zhang, Kai Yao, Junhang Luo, Hui Han
Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy. Cancer 130 (9) (2023)
Lichao Wei, Zaishang Li, Sheng-Jie Guo, Huali Ma, Yanxia Shi, Xin An, Kangbo Huang, Longbin Xiong, Ting Xue, Zhiling Zhang, Kai Yao, Junhang Luo, Hui Han
Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy. Cancer 130 (9) (2023)
Xin An, Cong Xue, Meiting Chen, Mengqian Ni, Huali Ma, Li Tian, Riqing Huang, Xiangdong Li, Yun-Lin Ye, Tao Qin, Pei Dong, Fangjian Zhou, Jing Peng, Kai Yao, Fangjian Zhou, Zhuo-Wei Liu, Yanxia Shi
Gemcitabine/Nab-Paclitaxel versus Gemcitabine/Carboplatin for Advanced Urothelial Carcinoma. BJU international (2023)
Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Mei-Ting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shu-Sen Wang, Yanxia Shi, Xin An
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Cancer medicine (2023)
Xin An, Xuefen Lei, Riqing Huang, Rongzhen Luo, Haifeng Li, Fei Xu, Zhongyu Yuan, Shu-Sen Wang, Alexandre de Nonneville, Anthony Gonçalves, Gilles Houvenaeghel, JiBin Li, Cong Xue, Yanxia Shi
Adjuvant chemotherapy for small, lymph node-negative, triple-negative breast cancer: A single-center study and a meta-analysis of the published literature. Cancer (2021)
Guoxue Tang, Xin An, Huiling Xiang, Lixian Liu, Anhua Li, Xi Lin
Automated Breast Ultrasound: Interobserver Agreement, Diagnostic Value, and Associated Clinical Factors of Coronal-Plane Image Features. Korean journal of radiology 21 (5) (2020)
Zhi-Hua Liu, Mei-Ling Chen, Qi Zhang, Yu Zhang, Xin An, Yi-Ling Luo, Xue-Min Liu, Shang-Xin Liu, Qian Liu, Ting Yang, Yan-Min Liu, Bin-Liu Liu, Ai-Jun Zhou, Man-Zhi Li, Yu-Jie Liu, Ze-Xian Liu, Qian Zhong
ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer. International journal of cancer 147 (2) (2020)

Xin An.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xin An